首页
学术期刊
论文检测
AIGC检测
热点
更多
数据
BCGAcute tubulointerstitial nephritis: case report
被引:0
|
作者
:
机构
:
来源
:
Reactions Weekly
|
2024年
/ 2031卷
/ 1期
关键词
:
D O I
:
10.1007/s40278-024-69351-x
中图分类号
:
学科分类号
:
摘要
:
引用
收藏
页码:71 / 71
相关论文
共 50 条
[41]
AdalimumabUnmasking of tubulointerstitial nephritis and uveitis: case report
Reactions Weekly,
2021,
1838
(1)
: 20
-
20
[42]
MesalazineAcute tubulointerstitial nephritis and glomerulosclerosis: case report
Reactions Weekly,
2023,
1957
(1)
: 356
-
356
[43]
Nivolumab/rabeprazoleAcute tubulointerstitial nephritis: case report
Reactions Weekly,
2018,
1730
(1)
: 236
-
236
[44]
SitagliptinAcute tubulointerstitial nephritis (ATIN): case report
Reactions Weekly,
2016,
1616
(1)
: 142
-
142
[45]
MesalazineAcute and chronic tubulointerstitial nephritis: case report
Reactions Weekly,
2023,
1966
(1)
: 205
-
205
[46]
EscitalopramAcute interstitial nephritis leading to tubulointerstitial nephritis and uveitis: case report
Reactions Weekly,
2023,
1960
(1)
: 192
-
192
[47]
FlurbiprofenFirst report of tubulointerstitial nephritis and uveitis syndrome: case report
Reactions Weekly,
2013,
1438
(1)
: 17
-
17
[48]
PembrolizumabIgG4-tubulointerstitial nephritis: case report
Reactions Weekly,
2024,
2036
(1)
: 388
-
388
[49]
OmeprazoleAcute tubulointerstitial nephritis and polyclonal hypergammaglobulinaemia: case report
Reactions Weekly,
2019,
1737
(1)
: 228
-
228
[50]
Entrectinib-induced tubulointerstitial nephritis: a case report
Stempler, Mark
论文数:
0
引用数:
0
h-index:
0
机构:
Semmelweis Univ, Dept Internal Med & Oncol, Budapest, Hungary
Semmelweis Univ, Dept Internal Med & Oncol, Budapest, Hungary
Stempler, Mark
Dobi, Dejan
论文数:
0
引用数:
0
h-index:
0
机构:
Semmelweis Univ, Dept Pathol, Forens & Insurance Med, Budapest, Hungary
Semmelweis Univ, Dept Internal Med & Oncol, Budapest, Hungary
Dobi, Dejan
Ledo, Nora
论文数:
0
引用数:
0
h-index:
0
机构:
Semmelweis Univ, Dept Internal Med & Oncol, Budapest, Hungary
Semmelweis Univ, Dept Internal Med & Oncol, Budapest, Hungary
Ledo, Nora
INTERNATIONAL JOURNAL OF SURGERY-ONCOLOGY,
2023,
8
(04):
: 35
-
38
←
1
2
3
4
5
→